China's Imports of blood drug approved

Read More About Business

Unlike the banning drug blood of the past times, now China’s top drug authority is set to approve imports blood drug, a hemophilia treatment to help make up for a shortfall that has deprived some patients of the medication they need. The recombinant-clotting factor produced by the German pharmaceutical company Bayer Healthcare will be on the market soon, according to an announcement on the State Food and Drug Administration (SFDA) website.” This does not mean that we are easing the two-decade ban on imported blood drug and plasma-derived products of all kinds," SFDA spokeswoman Yan Jiangying said on Wednesday. Blood drug is going to China now.

The authorities imposed the blood drug ban in 1986, in response to a case of HIV infection caused by imported blood drug VIII that was detected around 1983.The German-made treatment does not fall into the category of products that are subject to the embargo because it is not made from human plasma, said Yin Hongzhang, a division director with the SFDA's department of drug registration. However, the recombinant-clotting factor has the same medical effect as plasma-derived blood drug VIII. It is widely used to treat hemophiliacs in China.

Many clinicians believe such blood drug treatments pose little risk of transmitting an infectious disease. Larry Zhang, regional head for Asia Pacific of Bayer Healthcare, said the blood drug treatment would be made available at a lower price in China than in other countries because of the financial difficulties that many patients here face and the lack of a comprehensive health insurance scheme. Recombinant-clotting factor will cost no more than 5 Yuan (65 cents) in China, Zhang said. The average international price is 30 Yuan.

A unit of blood drug VIII currently costs more than 1 Yuan in China. In case of a hemorrhage, 1,000 units are required to stop a potentially fatal bout of bleeding. Chu Yuguang, a Beijing-based hemophiliac and the director of the Hemophilia Home of China, a volunteer group of more than 3,000 patients, applauded the plan to import recombinant-clotting blood drug factor, describing it as a timely measure by the government.

"However, many patients cannot even afford locally made blood drug VIII, let alone the much more expensive import," Chu said. In another development, recombinant-clotting blood drug factor donated by Bayer Healthcare, enough for roughly 650 patients, is on its way from the US to China and should arrive at six Chinese hospitals next week, Zhang said.

Article Source: http://depositarticles.com/

news.tootoo.com, which is the shortcut to China's industrical resource belonging to China's leading B2B Portal and Vertical Search Engine, tootoo.com.

Please Rate this Article

Not yet Rated

Click the XML Icon Above to Receive Business Articles Via RSS!

Additional Articles From - Home | Business

Our other websites
All about SEO
Beauty Tips Forum

	Print This Article
	Post Comment
	Add To Favorites
	Email to Friends
	Ezine Ready

Submit Articles
Member Login
Link Us
Submission Guidelines
Ezine Notifications
Article RSS Feeds
Sitemap

New Stuff
About Us
Developer
Good shopping portal
Link to Us
Contact Us
Privacy Policy
Terms of Service